CRSP Market Cap & Key Metrics
CRISPR Therapeutics AG
$55.35
-$0.08(-0.14%)
58
Overall
60
Value
66
Tech
50
Quality
Market Cap
$5.36B
Volume
345.19K
52W Range
$44.12 - $78.48
Target Price
$85.06
CRSP market cap is $5.36B. This page lists CRISPR Therapeutics AG's P/E ratio, EPS estimates, dividend yield, payout ratio and MarketXLS scores.
CRSP Key Metrics
- Market cap
- $5.36B
- EPS estimate, current year
- $-4.47
- EPS growth, 3-year
- +8.19%
- Value score
- 60
- Quality score
- 50
- Technical score
- 66
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $3.51M | $37.31M | $371.21M | $1.20M | $914.96M |
| EBITDA | -$558.49M | -$343.41M | -$130.88M | -$626.33M | $391.48M |
| EPS | $-6.47 | $-4.34 | $-1.94 | $-8.36 | $4.97 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CRSP | $55.35 | -0.1% | 345.19K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |